Abstract
Previously, we showed that expression of nm23-H1 is associated inversely with sensitivity to cisplatin in human oesophageal squamous cell carcinoma (OSCC). The present study was undertaken to investigate the association of nm23-H1 expression with cisplatin-induced DNA damage in OSCC using antisense nm23-H1 transfectants. YES-2/AS-12, an antisense nm23-H1-transfected OSCC cell line, showed significantly reduced expression of intracellular nm23-H1 protein compared with that in parental YES-2 cells and YES-2/Neo transfectants. Surface expression of nm23-H1 protein was not observed in any of the three cell lines. PCR analysis for DNA damage demonstrated that YES-2/AS-12 cells were more resistant to nuclear and mitochondrial DNA damage by cisplatin than were YES-2/Neo cells. In addition, mitochondrial membrane potentials and DNA fragmentation assays confirmed that YES-2/AS-12 was more resistant than YES-2/Neo to apoptosis induced by cisplatin. In contrast, YES-2/AS-12 was more sensitive to ouabain, a selective inhibitor of Na+, K+-ATPase, than YES-2 and YES-2/Neo. Pre-treatment with ouabain resulted in no differences in cisplatin sensitivity between the three cell lines examined. Intracellular platinum level in YES-2/AS-12 was significantly lower than that in YES-2 and YES-2/Neo following incubation with cisplatin, whereas ouabain pre-treatment resulted in no differences in intracellular platinum accumulations between the three cell lines. Our data support the conclusion that reduced expression of intracellular nm23-H1 in OSCC cells is associated with cisplatin resistance via the prevention of both nuclear and mitochondrial DNA damage and suggest that it may be related to Na+, K+-ATPase activity, which is responsible for intracellular cisplatin accumulation. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Andrews PA, Mann SC, Huynh HH and Albright KD (1991) Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells. Cancer Res 51: 3677–3681
Blok LJ, Chang GT, Steenbeek-Slotboom M, van Weerden WM, Swarts HG, De Pont JJ, van Steenbrugge GJ and Brinkmann AO (1999) Regulation of expression of Na+, K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer 81: 28–36
Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M and Sahmoud T (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161–167
Daoud SS, Clements MK and Small CL (1995) Polymerase chain reaction analysis of cisplatin-induced mitochondrial DNA damage in human ovarian carcinoma cells. Anti-Cancer Drugs 6: 405–412
Eguchi Y, Srinivasan A, Tomaselli KJ, Shimizu S and Tsujimoto Y (1999) ATP-dependent steps in apoptotic signal transduction. Cancer Res 59: 2174–2181
Ferguson AW, Flatow U, MacDonald NJ, Larminat F, Bohr VA and Steeg PS (1996) Increased sensitivity to cisplatin by nm23-transfected tumor cell lines. Cancer Res 56: 2931–2935
Freije JM, Lawrence JA, Hollingshead MG, De la Rosa A, Narayanan V, Grever M, Sausville EA, Paull K and Steeg PS (1997) Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines. Nature Med 4: 395–401
Fulda S, Lutz W, Schwab M and Debatin KM (1999) MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene 18: 1479–1486
Hazama S, Noma T, Wang F, Iizuka N, Ogura Y, Yoshimura K, Inoguchi E, Hakozaki M, Hirose K, Suzuki T and Oka M (1999) Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo. Br J Cancer 80: 1420–1426
Higashiyama M, Doi O, Yokouchi H, Kodama K, Nakamori S, Tateishi R and Kimura N (1992) Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value. Br J Cancer 66: 533–536
Hishikawa Y, Abe S, Kinugasa S, Yoshimura H, Monden N, Igarashi M, Tachibana M and Nagasue N (1997) Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. Oncology 54: 342–347
Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K and Suzuki T (1995) NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res 55: 652–657
Iizuka N, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T and Oka M (1999a) The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma. Cancer Lett 138: 139–144
Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K and Oka M (1999b) The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Br J Cancer 81: 469–475
Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S and Oka M (2000) Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 148: 19–25
Ishikawa N, Shimada N, Munakata Y, Watanabe K and Kimura N (1992) Isolation and characterization of a gene encoding rat nucleoside diphosphate kinase. J Biol Chem 267: 14366–14372
Kalinowski DP, Illenye S and Van Houten B (1992) Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay. Nucleic Acids Res 20: 3485–3494
Kim CN, Wang X, Huang Y, Ibrado AM, Liu L, Fang G and Bhalla K (1997) Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res 57: 3115–3120
Kok TC, Van der Gaast A, Dees J, Eykenboom WM, Van Overhagen H, Stoter G, Tilanus HW and Splinter TA (1996) Cisplatin and etoposide in oesophageal cancer: a phase II study. Br J Cancer 74: 980–984
Kroemer G, Dallaporta B and Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619–642
Leone A, Flatow U, VanHoutte K and Steeg PS (1993) Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8: 2325–2333
Lindmark G (1996) NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer 74: 1413–1418
Mann SC, Andrews PA and Howell SB (1991) Modulation of cis-diamminedichloroplatinum (II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 48: 866–872
Marshall LJ, Muimo R, Riemen CE and Mehta A (1999) Na+ and K+ regulate the phosphorylation state of nucleoside diphosphate kinase in human airway epithelium. Am J Physiol 276: C109–119
Ohmori T, Nishio K, Ohta S, Kubota N, Adachi M, Komiya K and Saijo N (1994) Ouabain-resistant non-small-cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP). Int J Cancer 57: 111–116
Oka M, Iizuka N, Yamamoto K, Gondo T, Abe T, Hazama S, Akitomi Y, Koshihara Y, Ohsugi Y, Ooba Y, Ishihara T and Suzuki T (1996a) The influence of interleukin-6 on the growth of human esophageal cancer cell lines. J Interferon Cytokine Res 16: 1001–1006
Oka M, Hirazawa K, Yamamoto K, Iizuka N, Hazama S, Suzuki T and Kobayashi N (1996b) Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg 223: 434–440
Olivero OA, Semino C, Kassim A, Lopez-Larraza DM and Poirier MC (1995) Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells. Mutation Res 346: 221–230
Olivero OA, Chang PK, Lopez-Larraza DM, Semino-Mora MC and Poirier MC (1997) Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutation Res 391: 79–86
O'Neill CF, Koberle B, Masters JRW and Kelland LR (1999) Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resitant to cisplatin. Br J Cancer 81: 1294–1303
Otero AS, Doyle MB, Hartsough MT and Steeg PS (1999) Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization of muscarinic potassium current. Biochim Biophys Acta 1449: 157–168
Russell RL, Pedersen AN, Kantor J, Geisinger K, Long R, Zbieranski N, Townsend A, Shelton B, Brunner N and Kute TE (1998) Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines. Br J Cancer 78: 710–717
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB and Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491
Scambia G, Ferrandina G, Marone M, Benedetti PP, Giannitelli C, Piantelli M, Leone A and Mancuso S (1996) Nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. J Clin Oncol 14: 334–342
Shimada M, Taguchi K, Hasegawa H, Gion T, Shirabe K, Tsuneyoshi M and Sugimachi K (1998) Nm23-H1 expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma. Liver 118: 337–342
Stahl JA, Leone A, Rosengard AM, Potter L, King CR and Steeg PS (1991) Identification of a second human nm23 gene, nm23-H2. Cancer Res 51: 445–449
Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JB, Liotta LA and Sobel M (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200–204
Timmer-Bosscha H, Timmer A, Meijer C, de Vries EG, de Jong B, Oosterhuis JW and Mulder NH (1993) cis-diamminedichloroplatinum (ii) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res 53: 5707–5713
Tokunaga Y, Urano T, Furukawa K, Kondo K, Kanematsu T and Shiku H (1993) Reduced expression of nm23-H1, but not of nm23-H2 is concordant with the frequency of lymph node metastasis of human breast cancer. Int J Cancer 55: 66–71
Urano T, Furukawa K and Shiku H (1993) Expression of nm23/NDP kinase proteins on the cell surface. Oncogene 8: 1371–1376
Willems R, Van Bockstaele DR, Lardon F, Lenjou M, Nijs G, Snoeck HW, Berneman ZN and Slegers H (1998) Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation. J Biol Chem 273: 13663–13668
Yoon KL, Modica-Napolitano JS, Ernst SG and Aprille JR (1991) Denaturing gradient gel method for mapping single base changes in human mitochondrial DNA. Anal Biochem 196: 427–432
Zaborina O, Li X, Cheng G, Kapatral V and Chakrabarty AM (1999) Secretion of ATP-utilizing enzymes, nucleoside diphosphate kinase and ATPase, by Mycobacterium bovis BCG: sequestration of ATP from macrophage P2Z receptors? Mol Microbiol 31: 1333–1343
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
lizuka, N., Miyamoto, K., Tangoku, A. et al. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na+, K+-ATPase. Br J Cancer 83, 1209–1215 (2000). https://doi.org/10.1054/bjoc.2000.1436
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1436
Keywords
This article is cited by
-
Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells
BioMetals (2016)
-
ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer
Medical Oncology (2011)
-
CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Medical Oncology (2011)
-
Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B
Cancer Chemotherapy and Pharmacology (2009)
-
Role of Na+, K+-ATPase α1 subunit in the intracellular accumulation of cisplatin
Cancer Chemotherapy and Pharmacology (2006)